Salmeterol/fluticasone propionate (50/100 μg) in combination in a diskus(TM) inhaler (seretide(TM)) is effective and safe in children with asthma

Pediatric Pulmonology

Volumn 30, Issue 2, 2000, Pages 97-105

  Van Schaik, S M ^a   Welliver, R C ^a   Kimpen, J L L ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Asthma; Children; Dry powder inhaler; Fluticasone propionate; Inhaled corticosteroids; Randomized clinical trial; Salmeterol

Indexed keywords

FLUTICASONE PROPIONATE; SALMETEROL; SALMETEROL PLUS FLUTICASONE;

ARTICLE; ASTHMA; ATOPIC DERMATITIS; BEHAVIOR DISORDER; CANDIDIASIS; CARDIOTOXICITY; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CUSHING DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HOARSENESS; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; PATIENT SELECTION; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREMOR;

ADMINISTRATION, INHALATION; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; NEBULIZERS AND VAPORIZERS; TREATMENT OUTCOME;

EID: 0033860390     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0496(200008)30:2<97::AID-PPUL4>3.0.CO;2-P     Document Type: Article

References (39)

1. Trends in prevalence and severity of childhood asthma
2. Recent trends in the prevalence and severity of childhood asthma
3. Epidemiology of childhood asthma
4. Burden of paediatric asthma
5. The burden of pediatric asthma
6. Increase in hospital admissions for childhood asthma: Trends in referral, severity and readmission from 1970 to 1985 in a health region of the United Kingdom
7. British guidelines on asthma management: 1995 review and position statement
8. Global strategy for asthma management and prevention
9. Inhaled glucocorticoids for asthma
10. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
11. Effect of early vs. late intervention with inhaled corticosteroids in asthma
12. Use of inhaled corticosteroids in pediatric asthma
13. Managing symptoms and exacerbations in pediatric asthma
14. A comparison of in-vitro drug delivery from salbutamol Diskus and terbutaline Turbohaler inhalers
15. Development of a dry powder inhaler device containing a combination of salmeterol and fluticasone propionate
16. Clinical effect of Diskus dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children
17. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients
18. Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma
19. The role of inhaled fluticasone propionate, efficacy and safety
20. Inhaled fluticasone propionate dry powder administered via the Diskus or Diskhaler is safe and effective in pediatric patients with chronic asthma
21. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 μg/day with inhaled beclomethasone dipropionate 400 μg/day in mild to moderate asthma
22. A comparison of fluticasone propionate 100 μg twice daily, with budesonide, 200 μg twice daily via their respective powder devices in the treatment of mild asthma
23. Fluticasone propionate and budesonide in adult asthmatics: A comparison using dry-powder inhaler devices
24. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma
25. Efficacy and use of fluticasone propionate multidose powder inhaler compared with budesonide reservoir powder device in asthmatic children
26. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
27. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
28. Inhaled salmeterol and fluticasone propionate therapy in moderate adult asthma
29. Addition of salmeterol vs. doubling the dose of beclomethasone in children with asthma
30. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: A dose response study
31. Growth in asthmatic children treated with fluticasone propionate
32. Long-term study to compare safety and efficacy of fluticasone propionate (FP) with beclomethasone dipropionate (BDP) in asthmatic children
33. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: A comparison of fluticasone with beclomethasone
34. Inhaled glucocorticoids: New developments relevant to updating of the Asthma Management Guidelines
35. Nocturnal adrenal suppression in asthmatic children taking inhaled beclomethasone dipropionate
36. Bloodspot cortisol in mild asthma: The effect of inhaled corticosteroids
37. Adrenal function in asthma
38. Compliance with inhaled asthma medication in preschool children
39. 2 agonists